# Application of Osteopathic Manipulative Treatment (OMT) in Neurodegenerative Disorders: A Scoping Review

## TL;DR

This review explores the potential of osteopathic manipulative treatment (OMT) in managing symptoms of neurodegenerative diseases like Parkinson's and Alzheimer's, finding some promise but highlighting the need for more research.

## Contribution

The study maps the current evidence and identifies research gaps in using OMT for neurodegenerative disorders.

## Key findings

- OMT may improve postural stability and balance in Parkinson's disease patients.
- Preclinical studies suggest OMT can reduce amyloid β protein levels and modulate cytokines in Alzheimer's dementia.
- ALS patients reported high satisfaction with OMT, though no significant clinical improvements were observed.

## Abstract

Neurodegenerative diseases are comprised of a host of chronic conditions that impair the central nervous system. Osteopathic manipulative treatment (OMT) consists of many non-invasive modalities that can be used to treat a wide variety of ailments and conditions. OMT is reported to increase the range of motion and lymphatic flow, as well as decrease pain in a wide array of disorders. However, the efficacy of using OMT in neurodegenerative disorders has not been well established.

The objective of this scoping review is to map the evidence that pertains to the application of OMT in treating neurodegenerative disorders and identify the gaps in the literature on this subject. This study was designed according to the Joanna Briggs Institute (JBI) guidelines for scoping reviews to gather information on OMT’s potential efficacy in managing Parkinson’s disease (PD), Alzheimer’s disease (AD) dementia, amyotrophic lateral sclerosis (ALS), and Huntington’s disease (HD). Peer-reviewed literature was collected through the Excerpta Medica database (EMBASE), Ovid Medical Literature Analysis and Retrieval System Online (MEDLINE), and Web of Science. The criteria were limited to papers in English published between 1999 and 2023. The following search string was utilized: “osteopathic manipulative treatment” OR “osteopathic manipulation” AND “neurodegenerative disorders” OR “Alzheimer’s disease” OR "dementia” OR “amyotrophic lateral sclerosis” OR “Parkinson’s disease” OR “Huntington’s chorea”.

One hundred and forty-three articles were identified following final screening and critical appraisal, with eleven articles selected for analysis in this study. Data from the selected articles demonstrated that OMT can possibly attenuate symptoms in patients diagnosed with neurodegenerative diseases. Studies in rats showed that OMT techniques were found to alter cholinergic neuronal genes, improve spatial learning and memory, reduce amyloid β protein levels, modulate synaptic transmission, and increase levels of the cytokines IL-1, IL-10, IL-13, RANTES, IL-17A, and EOTAXIN effects in AD dementia. ALS patients demonstrated a high level of satisfaction with OMT and did not report any adverse effects, though there was no decrease in pain or increased quality of life reported. PD patients reported improved postural stability, balance, and gait after OMT. No results were returned regarding OMT’s effects on HD.

Preliminary results in human PD and ALS patients who received OMT as an adjunct to traditional treatment regimens showed promising results, though few studies were found that address the topic, and the sample sizes of the studies that were found were small. There were no studies of the effects of OMT on human patients with AD or HD found, though preclinical studies in rats supported their trial in subsequent human studies. While current research on the impact of OMT on these neurodegenerative diseases is promising, there remain large gaps in the literature. Further research is necessary to support the use of and long-term efficacy of OMT in neurodegenerative diseases.